STOCK TITAN

Casi Pharmaceuticals Inc (CASI) Revenue by Year

CASI

Casi Pharmaceuticals Inc generated $20.7M in revenue in fiscal year 2025. This represents a decrease of 27.4% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Casi Pharmaceuticals Inc has filed alongside them.

FY2025 annual
Revenue $20.7M
YoY -27.4%
5Y CAGR +6.5%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CASI Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY22FY21FY20
Revenue$20.7M-27.4%$28.5M-15.8%$33.9M-21.4%$43.1M+42.9%$30.2M+99.2%$15.1M

CASI Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ4'2410-KQ4'23Q4'22Q4'21
RevenueN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Casi Pharmaceuticals Inc financials

Frequently Asked Questions

What was Casi Pharmaceuticals Inc's revenue in fiscal year 2025?

Casi Pharmaceuticals Inc generated $20.7M in revenue in fiscal year 2025.

How fast is Casi Pharmaceuticals Inc's revenue growing?

Casi Pharmaceuticals Inc (CASI) revenue fell by 27.4% year over year, from $28.5M to $20.7M in fiscal year 2025.

How has Casi Pharmaceuticals Inc's revenue changed over the years?

Across the 6 fiscal years this page covers, Casi Pharmaceuticals Inc (CASI) revenue went from $15.1M in fiscal year 2020 to $20.7M in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Casi Pharmaceuticals Inc (CASI) reported on that line in every period on record.